Mice tumor free and protected from metastases after treatment
The shells of a common plant virus, inhaled into a lung tumor or injected into ovarian, colon or breast tumors, not only triggered the immune system in mice to wipe out the tumors, but provided systemic protection against metastases, researchers from Case Western Reserve University and Dartmouth University report.
The scientists tested a 100-year-old idea called in-situ vaccination. The idea is to put something inside a tumor and disrupt the environment that suppresses the immune system, thus allowing the natural defense system to attack the malignancy.
That something–the hard coating of cowpea mosaic virus–caused no detectible side effects, which are a common problem with traditional therapies and some immunotherapies.
The team’s research is published in the journal Nature Nanotechnology.
“The cowpea virus-based nanoparticles act like a switch that turns on the immune system to recognize and fight against the tumor – as well as to remember it,” said Nicole Steinmetz, an assistant professor of biomedical engineering at Case Western Reserve, appointed by the Case Western Reserve School of Medicine.
“The particles are shockingly potent,” said Steven Fiering, professor of microbiology and immunology at Dartmouth’s Geisel School of Medicine. “They’re easy to make and don’t need to carry antigens, drugs or other immunostimmulatory agents on their surface or inside.”
The professors studied the nanoparticles with Dartmouth’s Pat Lizotte, a molecular and cellular biology PhD student; Mee Rie Sheen, a postdoctoral fellow; and Pakdee Rojanasopondist, an undergraduate student; and Case Western Reserve’s Amy Wen, a biomedical engineering PhD student.
Taking another shot
The immune system’s ability to detect and destroy abnormal cells is thought to prevent many cancers, according to the National Cancer Institute. But when tumors start to develop, they can shut down the system, allowing tumors to grow and spread.
To restart immune defenses, the scientists used the tumor itself as if it were the antigen in a vaccine–that is, the target for antibodies produced by the immune system.
The cowpea virus shell, with its infectious components removed, acts as the adjuvant–a substance that triggers and may enhance or prolong antigen-specific immune responses.
The process and results
The researchers first switched on the immune system in mice to attack B16F10 lung melanoma or skin melanoma, leaving the mice tumor-free. When the treated mice were later injected with B16F10 skin melanoma (to re-challenge the cured mice), four out of five mice were soon cancer free and one had a slow-growing tumor.
The nanoparticles proved effective against ovarian, breast and colon tumor models. Most of the tumors deteriorated from the center and collapsed. The systemic response prevented or attacked metastatic disease, which is the deadliest form of cancer.
“You get benefits against disease you don’t even know is there yet,” Fiering said.
“Because everything we do is local, the side effects are limited,” despite the strength and extent of the immune response, Fiering said. No toxicity was found.
Harsh side effects, such as fatigue, pain, flu-like symptoms and more are common with chemo and radiation therapies and with some immunostimulation drugs.
The researchers are now trying to understand how the virus shell stimulates the immune system.
“It’s not cytotoxic, there’s no RNA involved or lipopolysaccharides that may be used as adjuvants, and it’s not simply an irritant,” Steinmetz said. “We see a specific immune response.”
The Latest on: Immune response against cancer
via Google News
The Latest on:Iimmune response against cancer
- Fred Hutch studies immune response to COVID-19, needs participantson June 26, 2020 at 4:33 pm
Researchers have a tent set up in a loading dock at Fred Hutch to interview and test participants. Each participant has a 45 -minute interview and informational meeting. Subjects will have a nasal ...
- Synthesis of bioactive natural compounds for the battle against canceron June 25, 2020 at 2:41 pm
Phytoalexins are bioactive phytochemicals that have attracted much attention in recent years due to their health-promoting effects in humans and their vital role in plant health.
- Bioactive natural compounds for the fight against canceron June 25, 2020 at 10:04 am
Phytoalexins are bioactive phytochemicals that have attracted much attention in recent years due to their health-promoting effects in humans and their vital role in plant health. Chemists at TU ...
- Certain genes that predispose to cancer also affect the immune system, study showson June 25, 2020 at 9:49 am
The study shows that the involvement of certain genes that predispose to cancer also affects the immune system, which could facilitate tumor growth.
- Genes that predispose to cancer by impairing the immune systemon June 25, 2020 at 8:02 am
The idea that the immune system 'monitors and prevents' the development of cancer, which is called 'cancer immune vigilance," was initially proposed at the beginning of the last century. Since then, ...
- Identified genes that predispose to cancer by impairing the immune systemon June 25, 2020 at 7:16 am
The study shows that the involvement of certain genes that predispose to cancer also affects the immune system, which could facilitate tumor growth. In the specific case of breast cancer, the ...
- Synthetic immune cell rallies the troops to fight canceron June 25, 2020 at 12:06 am
Immunotherapy is a promising potential treatment for cancer, but it still has kinks to iron out. In a new study from Yale, researchers have identified a “jamming signal” that cancer uses to hide from ...
- ChemoCentryx Identifies Novel Orally Administered Immune Checkpoint Inhibitor CCX559 for Next Generation Cancer Treatmenton June 24, 2020 at 11:28 am
ChemoCentryx, Inc., (CCXI) today announced that it has identified an orally administered checkpoint inhibitor, CCX559, and plans to initiate clinical development in the first half of 2021. Data to be ...
- Regeneron identifies new combos to boost I-O drug Libtayo's cancer responseon June 24, 2020 at 11:00 am
Looking for ways to improve responses to PD-1 inhibitors in cancer, scientists at Regeneron turned to bispecific antibodies that bridge T cells and tumor cells. A new study showed that a combination ...
- New Immunotherapy Combinations Look to Create Maximum Velocity in Immune Systems Response to Canceron June 23, 2020 at 3:52 pm
After Susan Raphael received a diagnosis of pancreatic cancer in October 2018, she was treated successfully with surgery, radiation and 12 rounds of chemotherapy. Then, in February 2020, a PET scan ...
via Bing News